20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T74982 | Akt3 degrader 1 | ||
Akt3 Degrader 1 (compound 12l), a selective Akt3 degrader, effectively overcomes Osimertinib-induced resistance in H1975OR NSCLC cells. Besides its role in overcoming drug resistance, it exhibits anti-proliferative prope... | |||
T3467 | Miransertib | ARQ-092,AKT inhibitor 2 | Akt , Parasite |
Miransertib (ARQ-092) is an orally bioavailable, selective, and potent allosteric Akt inhibitor. | |||
T11928 | M2698 | MSC2363318A | Akt , mTOR |
M2698 (MSC2363318A) is an inhibitor of p70S6K, Akt1 and Akt3 with IC50s of 1 nM. M2698 shows anti-cancer activity. | |||
T15374 | Ipatasertib dihydrochloride | GDC-0068 dihydrochloride,RG-7440 dihydrochloride | Akt , PKA |
Ipatasertib dihydrochloride (GDC-0068 dihydrochloride) is a highly selective and ATP-competitive inhibitor of pan-Akt (IC50s: 5, 18 and 8 nM for Akt1, Akt2 and Akt3, respectively). | |||
T7885 | Afuresertib hydrochloride | ROCK , Akt , PKC | |
Afuresertib hydrochloride is an inhibitor of Akt kinase (Kis of 0.08/2/2.6 nM for Akt1/Akt2/Akt3 respectively) | |||
T14072 | A-443654 | ERK , VEGFR , GSK-3 , FLT , Casein Kinase , MAPK , Akt , PKA , Chk , CDK , Src , PKC , S6 Kinase | |
A-443654 is a pan-Akt inhibitor. A-443654 has equal potency against Akt1, Akt2, or Akt3 within cells (Ki=160 pM). | |||
T38846 | Vevorisertib trihydrochloride | ARQ 751 trihydrochloride | Akt |
Vevorisertib trihydrochloride (ARQ 751 trihydrochloride) is a selective and potent inhibitor of pan-AKT and AKT1-E17K mutations, inhibiting AKT1, AKT2 and AKT3. Vevorisertib trihydrochloride is used in the study of hepat... | |||
T1952 | MK-2206 dihydrochloride | MK-2206 2HCl | Apoptosis , Akt , Autophagy |
MK-2206 dihydrochloride (MK-2206 2HCl) is a variant Akt inhibitor that inhibits Akt1, Akt2, and Akt3 (IC50=8/12/65 nM) with orally active, highly potent and selective potency. MK-2206 dihydrochloride exhibits antitumor a... | |||
T39733 | Hu7691 free base | Akt | |
Hu7691 free base is an orally active, potent and selective Akt inhibitor with anti-proliferative and neurogenic effects on a variety of neuroblastoma cell lines.Hu7691 free base inhibits Akt1, Akt2, and Akt3 and induces ... | |||
T1920 | Capivasertib | AZD5363 | Akt , PKA , mTOR , Autophagy |
Capivasertib (AZD5363) is a broad-spectrum AKT inhibitor with inhibitory activity against Akt1, Akt2, and Akt3 (IC50=3/7/7 nM) with oral activity. Capivasertib has antitumor activity for the treatment of breast cancer. | |||
T3346 | AKT inhibitor VIII | AKTi-1/2 | Apoptosis , Akt |
AKT inhibitor VIII (AKTi-1/2) is a highly specific Akt1/2 inhibitor (IC50: 58/210 nM). The selectivity for Akt1 is higher about 36-fold than Akt3. | |||
T6252 | Ipatasertib | GDC-0068,RG7440 | Akt |
Ipatasertib (GDC-0068) (GDC-0068), a highly specific pan-Akt inhibitor, targets Akt1/2/3 with IC50 of 5 nM/18 nM/8 nM, respectively. | |||
T1911 | Afuresertib | GSK2110183C,GSK2110183 | ROCK , Akt , PKC |
Afuresertib (GSK2110183) is an orally bioavailable inhibitor of the serine/threonine protein kinase Akt (protein kinase B) with potential antineoplastic activity. | |||
T6849 | Uprosertib | GSK2141795,GSK795 | Akt |
Uprosertib (GSK2141795) (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively. Phase 2. | |||
T6304 | AT7867 | Akt , PKA , S6 Kinase | |
AT7867 is a potent ATP-competitive inhibitor of Akt1/2/3 and p70S6K/PKA with IC50 of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively; little activity outside the AGC kinase family. | |||
T6285 | GSK-690693 | GSK690693 | Serine Protease , Akt , PKC , AMPK , Autophagy |
GSK-690693 is a pan-Akt inhibitor targeting Akt1/2/3 with IC50 of 2 nM/13 nM/9 nM, also sensitive to the AGC kinase family: PKA, PrkX and PKC isozymes. Phase 1. | |||
T2482 | AT13148 | ROCK , SGK , Akt , PKA , S6 Kinase | |
AT13148 is an oral-active and ATP-competitive, multi-AGC kinase inhibitor for Akt1/2/3, p70S6K, PKA, and ROCKI/II. | |||
T15428 | Uprosertib hydrochloride | GSK2141795 (hydrochloride) | Others |
Uprosertib hydrochloride is a potent and selective inhibitor of pan-Akt (IC50: 180/328/38 nM for Akt1/Akt2/Akt3, respectively). | |||
T39930 | MS98 | ||
MS98 is a highly effective and specific PROTAC AKT degrader compound that effectively targets and depletes total AKT (T-AKT) within cells, exhibiting a DC 50 value of 78 nM. This compound readily binds to AKT1, AKT2, and... | |||
T11664 | INY-03-041 | Others | |
INY-03-041, a potent and highly selective PROTAC-based pan-AKT degrader, inhibits AKT1, AKT2, and AKT3 with IC50s of 2.0 nM, 6.8 nM, and 3.5 nM, respectively. This compound consists of the ATP-competitive AKT inhibitor G... |